Kazuo Imagawa

Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes

Kazuo Takayama, Yuta Morisaki, Shuichi Kuno et al. · Proceedings of the National Academy of Sciences · 2014 · 190 citations · Full text

Infliximab for the Treatment of Refractory Kawasaki Disease: A Nationwide Survey in Japan

Hiroshi Masuda, Tohru Kobayashi, Akira Hachiya et al. · The Journal of Pediatrics · 2017 · 45 citations

Rheumatology, Refractory Kawasaki Disease, Pathology +2

Generation of a bile salt export pump deficiency model using patient-specific induced pluripotent stem cell-derived hepatocyte-like cells

Kazuo Imagawa, Kazuo Takayama, Shigemi Isoyama et al. · Scientific Reports · 2017 · 38 citations · Full text

Human ESC/iPSC-Derived Hepatocyte-like Cells Achieve Zone-Specific Hepatic Properties by Modulation of WNT Signaling

Seiji Mitani, Kazuo Takayama, Yasuhito Nagamoto et al. · Molecular Therapy · 2017 · 32 citations · Full text

Immunology, Cholangiopathies, Cellular Physiology +20

Genotyping NUDT15 can predict the dose reduction of 6-MP for children with acute lymphoblastic leukemia especially at a preschool age

Hisato Suzuki, Hiroko Fukushima, Ryoko Suzuki et al. · Journal of Human Genetics · 2016 · 29 citations · Full text

Hematological Malignancy, Oncology, Pediatric Hematology +9